![Novartis raises forecasts as top drug sales beat Wall Street estimates](https://www.biopharmadive.com/imgproxy/QUriN8s2QzLCAB_vrQ1RhChs6lxv6RWiUO5fdVJ4vx0/crop:3348:1892/g:nowe:0:156/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL3Rvd2VyLXdpdGgtc3Vycm91bmRpbmctYnVpbGRpbmdzLWltYWdlLmpwZw.webp)
Novartis raises forecasts as top drug sales beat Wall Street estimates
Sales of Novartis drugs for heart failure, psoriasis and multiple sclerosis were stronger over the first three months of the year than anticipated, helping the Swiss pharmaceutical company report first quarter earnings Tuesday that beat Wall Street forecasts. The drugmaker also raised its sales guidance for the year and now expects growth of high single…